Lantern Pharma is reinventing the cancer drug development process by tailoring multiple promising precision drug programs to the right cancer patients using advanced genomics and artificial intelligence. Lantern identifies, partners with, licenses or acquires abandoned, late-stage clinical drugs that are effective in only some patients from other companies.
Using advanced genomics, data analytics, and Artificial Intelligence, these valuable drugs are 'rescued' and 'repurposed' by using molecular profiling to identify the right patients who will respond positively. Patients will be screened for a response biomarker, stratified and treated in a very small focused clinical trial.
|Size (employees)||9 (est)|
Lantern Pharma total Funding
Lantern Pharma latest funding size
Time since last funding
|2 years ago|
Lantern Pharma investors
|Health Wildcatterswdxefcqufszuzezftuxetqsqxt, Bios Partners, Green Park & Golf Ventures, GPG Ventures|
Lantern Pharma has 93 Twitter Followers. The number of followers has increased 1.6% month over month and increased 28.1% quarter over quarter
When was Lantern Pharma founded?
Lantern Pharma was founded in 2013.
How many employees does Lantern Pharma have?
Lantern Pharma has 9 employees.
Who are Lantern Pharma competitors?
Competitors of Lantern Pharma include BenevolentAI, CytomX Therapeutics and Lescarden.
Where are Lantern Pharma offices?
Lantern Pharma has an office in Dallas.
How many offices does Lantern Pharma have?
Lantern Pharma has 1 office.